Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01619384 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Stress Reduction and the Microbiome

A NA study of Posttraumatic Stress Disorder and Irritable Bowel Syndrome, sponsored by Seattle Institute for Biomedical and Clinical Research.

Completed
Registry status
NA
Development phase
55
Enrollment target
1
Study location

NCT01619384 is a NA study of Posttraumatic Stress Disorder and Irritable Bowel Syndrome that has completed, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 55 participants, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01619384, a NA study of Posttraumatic Stress Disorder and Irritable Bowel Syndrome, has completed, sponsored by Seattle Institute for Biomedical and Clinical Research.

COMPLETED
Registry status
NA
Development phase
55 participants
Enrollment target
1
Study location

Study Summary

This proposed study aims to determine whether decreasing stress levels in persons with posttraumatic stress disorder (PTSD) can lead to a change in the intestinal microbiota, assessed 8 weeks after enrollment.

Interventions

  • BEHAVIORAL Mindfulness-Based Stress Reduction

Study Locations (1)

Washington

  • VA Puget Sound - Seattle

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2010-07
Est. Completion 2013-12
Phase NA

What the Registry Record Tells You About NCT01619384

The ClinicalTrials.gov registry entry for NCT01619384 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 117 other Posttraumatic Stress Disorder trials with a reported enrollment target (50% lower). The listed sponsor is Seattle Institute for Biomedical and Clinical Research, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Posttraumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-Based Stress Reduction is the first listed.

NCT01619384 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01619384 about?

NCT01619384 is a clinical study titled "Mindfulness-Based Stress Reduction and the Microbiome". This proposed study aims to determine whether decreasing stress levels in persons with posttraumatic stress disorder (PTSD) can lead to a change in the intestinal microbiota, assessed 8 weeks after enrollment.

What is the current status of trial NCT01619384?

This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2010-07. Estimated completion is 2013-12.

What conditions does trial NCT01619384 study?

This clinical trial studies the following conditions: Posttraumatic Stress Disorder, Irritable Bowel Syndrome.

What interventions are being tested in trial NCT01619384?

The interventions under investigation include: Mindfulness-Based Stress Reduction (BEHAVIORAL).

Who is sponsoring clinical trial NCT01619384?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01619384 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Posttraumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.